India
· Delayed Price · Currency is INR Marksans Pharma Company Description
Marksans Pharma Limited, together with its subsidiaries, engages in the research, manufacturing, marketing, and sale of pharmaceutical formulations in the United States, North America, Europe, the United Kingdom, Australia, New Zealand, and internationally.
The company offers products in the pain management, upper respiratory, cardiovascular, central nervous system, anti-diabetic, gastrointestinal, analgesics, upper respiratory, ear care, skincare, anticancer, anti-ulcerative, anti-allergy, antiviral, dietary, cardiac, dermatology, antihistamines, anti-fungal, anti-viral, laxatives, and cold and cough therapeutic areas.
It also produces a range of solid oral dosage forms, including tablets and hard gelatin capsules; soft gels; essential oils; ointments; and creams and liquids, as well as prescription drugs.
The company provides its products to supermarkets, high street retailers, pharmacy chains, and wholesalers.
Marksans Pharma Limited was incorporated in 1992 and is headquartered in Mumbai, India.
| Country | India |
| Founded | 1992 |
| Industry | Pharmaceutical Preparations |
| Employees | 1,141 |
| CEO | Mark Saldanha |
Contact Details
Address: Grandeur Mumbai, 400053 India | |
| Phone | 91 22 4001 2000 |
| Website | marksanspharma.com |
Stock Details
| Ticker Symbol | 524404 |
| Exchange | Bombay Stock Exchange |
| Fiscal Year | April - March |
| Reporting Currency | INR |
| SIC Code | 2834 |
Key Executives
| Name | Position |
|---|---|
| Mark Saldanha | Chief Executive Officer |
| Jitendra Sharma | Chief Financial Officer |
| Vishal Bhargava | Chief Operating Officer |